8-70138295-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000452400.7(NCOA2):āc.3066G>Cā(p.Gln1022His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000924 in 1,613,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000452400.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCOA2 | NM_006540.4 | c.3066G>C | p.Gln1022His | missense_variant | 15/23 | ENST00000452400.7 | NP_006531.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCOA2 | ENST00000452400.7 | c.3066G>C | p.Gln1022His | missense_variant | 15/23 | 1 | NM_006540.4 | ENSP00000399968 | P1 | |
NCOA2 | ENST00000518363.2 | c.444G>C | p.Gln148His | missense_variant | 3/11 | 2 | ENSP00000429132 | |||
NCOA2 | ENST00000522054.1 | n.97G>C | non_coding_transcript_exon_variant | 2/2 | 3 | |||||
NCOA2 | ENST00000518287.6 | c.*23G>C | 3_prime_UTR_variant, NMD_transcript_variant | 14/21 | 5 | ENSP00000430148 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000137 AC: 34AN: 247568Hom.: 0 AF XY: 0.000156 AC XY: 21AN XY: 134320
GnomAD4 exome AF: 0.0000548 AC: 80AN: 1460956Hom.: 0 Cov.: 30 AF XY: 0.0000537 AC XY: 39AN XY: 726716
GnomAD4 genome AF: 0.000453 AC: 69AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000470 AC XY: 35AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.3066G>C (p.Q1022H) alteration is located in exon 15 (coding exon 13) of the NCOA2 gene. This alteration results from a G to C substitution at nucleotide position 3066, causing the glutamine (Q) at amino acid position 1022 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at